Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
9,144
archived clinical trials in
Ocular

Safety and Efficacy of KPI-121 Compared to Placebo in Subjects With Dry Eye Disease
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
Status: Enrolling
Updated:  12/31/1969
International Eye Associates PA
mi
from
Ormond Beach, FL
Safety and Efficacy of KPI-121 Compared to Placebo in Subjects With Dry Eye Disease
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
Status: Enrolling
Updated: 12/31/1969
International Eye Associates PA
mi
from
Ormond Beach, FL
Click here to add this to my saved trials
Safety and Efficacy of KPI-121 Compared to Placebo in Subjects With Dry Eye Disease
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
Status: Enrolling
Updated:  12/31/1969
Perez Eye Center/International Research Center
mi
from
Tampa, FL
Safety and Efficacy of KPI-121 Compared to Placebo in Subjects With Dry Eye Disease
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
Status: Enrolling
Updated: 12/31/1969
Perez Eye Center/International Research Center
mi
from
Tampa, FL
Click here to add this to my saved trials
Safety and Efficacy of KPI-121 Compared to Placebo in Subjects With Dry Eye Disease
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
Status: Enrolling
Updated:  12/31/1969
Eye Care Centers Management/Clayton Eye Center
mi
from
Morrow, GA
Safety and Efficacy of KPI-121 Compared to Placebo in Subjects With Dry Eye Disease
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
Status: Enrolling
Updated: 12/31/1969
Eye Care Centers Management/Clayton Eye Center
mi
from
Morrow, GA
Click here to add this to my saved trials
Safety and Efficacy of KPI-121 Compared to Placebo in Subjects With Dry Eye Disease
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
Status: Enrolling
Updated:  12/31/1969
Chicago Cornea Consultants, LTD
mi
from
Hoffman Estates, IL
Safety and Efficacy of KPI-121 Compared to Placebo in Subjects With Dry Eye Disease
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
Status: Enrolling
Updated: 12/31/1969
Chicago Cornea Consultants, LTD
mi
from
Hoffman Estates, IL
Click here to add this to my saved trials
Safety and Efficacy of KPI-121 Compared to Placebo in Subjects With Dry Eye Disease
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
Status: Enrolling
Updated:  12/31/1969
Price Vision Group
mi
from
Indianapolis, IN
Safety and Efficacy of KPI-121 Compared to Placebo in Subjects With Dry Eye Disease
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
Status: Enrolling
Updated: 12/31/1969
Price Vision Group
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Safety and Efficacy of KPI-121 Compared to Placebo in Subjects With Dry Eye Disease
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
Status: Enrolling
Updated:  12/31/1969
John-Kenyon American Eye Institute
mi
from
New Albany, IN
Safety and Efficacy of KPI-121 Compared to Placebo in Subjects With Dry Eye Disease
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
Status: Enrolling
Updated: 12/31/1969
John-Kenyon American Eye Institute
mi
from
New Albany, IN
Click here to add this to my saved trials
Safety and Efficacy of KPI-121 Compared to Placebo in Subjects With Dry Eye Disease
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
Status: Enrolling
Updated:  12/31/1969
Cincinnati Eye Institute
mi
from
Edgewood, KY
Safety and Efficacy of KPI-121 Compared to Placebo in Subjects With Dry Eye Disease
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
Status: Enrolling
Updated: 12/31/1969
Cincinnati Eye Institute
mi
from
Edgewood, KY
Click here to add this to my saved trials
Safety and Efficacy of KPI-121 Compared to Placebo in Subjects With Dry Eye Disease
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
Status: Enrolling
Updated:  12/31/1969
Koffler Vision Group
mi
from
Lexington, KY
Safety and Efficacy of KPI-121 Compared to Placebo in Subjects With Dry Eye Disease
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
Status: Enrolling
Updated: 12/31/1969
Koffler Vision Group
mi
from
Lexington, KY
Click here to add this to my saved trials
Safety and Efficacy of KPI-121 Compared to Placebo in Subjects With Dry Eye Disease
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
Status: Enrolling
Updated:  12/31/1969
The Eye Care Institute
mi
from
Louisville, KY
Safety and Efficacy of KPI-121 Compared to Placebo in Subjects With Dry Eye Disease
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
Status: Enrolling
Updated: 12/31/1969
The Eye Care Institute
mi
from
Louisville, KY
Click here to add this to my saved trials
Safety and Efficacy of KPI-121 Compared to Placebo in Subjects With Dry Eye Disease
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
Status: Enrolling
Updated:  12/31/1969
Taustine Eye Center
mi
from
Louisville, KY
Safety and Efficacy of KPI-121 Compared to Placebo in Subjects With Dry Eye Disease
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
Status: Enrolling
Updated: 12/31/1969
Taustine Eye Center
mi
from
Louisville, KY
Click here to add this to my saved trials
Safety and Efficacy of KPI-121 Compared to Placebo in Subjects With Dry Eye Disease
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
Status: Enrolling
Updated:  12/31/1969
Ophthalmic Consultants of Boston
mi
from
Boston, MA
Safety and Efficacy of KPI-121 Compared to Placebo in Subjects With Dry Eye Disease
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
Status: Enrolling
Updated: 12/31/1969
Ophthalmic Consultants of Boston
mi
from
Boston, MA
Click here to add this to my saved trials
Safety and Efficacy of KPI-121 Compared to Placebo in Subjects With Dry Eye Disease
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
Status: Enrolling
Updated:  12/31/1969
Minnesota Eye Consultants
mi
from
Bloomington, MN
Safety and Efficacy of KPI-121 Compared to Placebo in Subjects With Dry Eye Disease
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
Status: Enrolling
Updated: 12/31/1969
Minnesota Eye Consultants
mi
from
Bloomington, MN
Click here to add this to my saved trials
Safety and Efficacy of KPI-121 Compared to Placebo in Subjects With Dry Eye Disease
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
Status: Enrolling
Updated:  12/31/1969
Tauber Eye Center
mi
from
Kansas City, MO
Safety and Efficacy of KPI-121 Compared to Placebo in Subjects With Dry Eye Disease
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
Status: Enrolling
Updated: 12/31/1969
Tauber Eye Center
mi
from
Kansas City, MO
Click here to add this to my saved trials
Safety and Efficacy of KPI-121 Compared to Placebo in Subjects With Dry Eye Disease
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
Status: Enrolling
Updated:  12/31/1969
Comprehensive Eye Care, Ltd/Vision Research Institute, LLC
mi
from
Washington, MO
Safety and Efficacy of KPI-121 Compared to Placebo in Subjects With Dry Eye Disease
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
Status: Enrolling
Updated: 12/31/1969
Comprehensive Eye Care, Ltd/Vision Research Institute, LLC
mi
from
Washington, MO
Click here to add this to my saved trials
Safety and Efficacy of KPI-121 Compared to Placebo in Subjects With Dry Eye Disease
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
Status: Enrolling
Updated:  12/31/1969
Abrams Eye Institute
mi
from
Las Vegas, NV
Safety and Efficacy of KPI-121 Compared to Placebo in Subjects With Dry Eye Disease
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
Status: Enrolling
Updated: 12/31/1969
Abrams Eye Institute
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Safety and Efficacy of KPI-121 Compared to Placebo in Subjects With Dry Eye Disease
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
Status: Enrolling
Updated:  12/31/1969
Raymond Fong, MDPC
mi
from
New York, NY
Safety and Efficacy of KPI-121 Compared to Placebo in Subjects With Dry Eye Disease
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
Status: Enrolling
Updated: 12/31/1969
Raymond Fong, MDPC
mi
from
New York, NY
Click here to add this to my saved trials
Safety and Efficacy of KPI-121 Compared to Placebo in Subjects With Dry Eye Disease
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
Status: Enrolling
Updated:  12/31/1969
Ophthalmic Consultants of Long Island
mi
from
Rockville Centre, NY
Safety and Efficacy of KPI-121 Compared to Placebo in Subjects With Dry Eye Disease
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
Status: Enrolling
Updated: 12/31/1969
Ophthalmic Consultants of Long Island
mi
from
Rockville Centre, NY
Click here to add this to my saved trials
Safety and Efficacy of KPI-121 Compared to Placebo in Subjects With Dry Eye Disease
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
Status: Enrolling
Updated:  12/31/1969
Cornerstone Eye Care
mi
from
High Point, NC
Safety and Efficacy of KPI-121 Compared to Placebo in Subjects With Dry Eye Disease
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
Status: Enrolling
Updated: 12/31/1969
Cornerstone Eye Care
mi
from
High Point, NC
Click here to add this to my saved trials
Safety and Efficacy of KPI-121 Compared to Placebo in Subjects With Dry Eye Disease
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
Status: Enrolling
Updated:  12/31/1969
James D. Branch, MD
mi
from
Winston-Salem, NC
Safety and Efficacy of KPI-121 Compared to Placebo in Subjects With Dry Eye Disease
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
Status: Enrolling
Updated: 12/31/1969
James D. Branch, MD
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Safety and Efficacy of KPI-121 Compared to Placebo in Subjects With Dry Eye Disease
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
Status: Enrolling
Updated:  12/31/1969
Comprehensive Eye Care of Central Ohio
mi
from
Westerville, OH
Safety and Efficacy of KPI-121 Compared to Placebo in Subjects With Dry Eye Disease
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
Status: Enrolling
Updated: 12/31/1969
Comprehensive Eye Care of Central Ohio
mi
from
Westerville, OH
Click here to add this to my saved trials
Safety and Efficacy of KPI-121 Compared to Placebo in Subjects With Dry Eye Disease
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
Status: Enrolling
Updated:  12/31/1969
Drs Fine Hoffman & Sims, LLC
mi
from
Eugene, OR
Safety and Efficacy of KPI-121 Compared to Placebo in Subjects With Dry Eye Disease
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
Status: Enrolling
Updated: 12/31/1969
Drs Fine Hoffman & Sims, LLC
mi
from
Eugene, OR
Click here to add this to my saved trials
Safety and Efficacy of KPI-121 Compared to Placebo in Subjects With Dry Eye Disease
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
Status: Enrolling
Updated:  12/31/1969
Eye Care Specialists
mi
from
Kingston, PA
Safety and Efficacy of KPI-121 Compared to Placebo in Subjects With Dry Eye Disease
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
Status: Enrolling
Updated: 12/31/1969
Eye Care Specialists
mi
from
Kingston, PA
Click here to add this to my saved trials
Safety and Efficacy of KPI-121 Compared to Placebo in Subjects With Dry Eye Disease
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
Status: Enrolling
Updated:  12/31/1969
Bucci Laser Vision Institute
mi
from
Wilkes-Barre, PA
Safety and Efficacy of KPI-121 Compared to Placebo in Subjects With Dry Eye Disease
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
Status: Enrolling
Updated: 12/31/1969
Bucci Laser Vision Institute
mi
from
Wilkes-Barre, PA
Click here to add this to my saved trials
Safety and Efficacy of KPI-121 Compared to Placebo in Subjects With Dry Eye Disease
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
Status: Enrolling
Updated:  12/31/1969
Chattanooga Eye Institute
mi
from
Chattanooga, TN
Safety and Efficacy of KPI-121 Compared to Placebo in Subjects With Dry Eye Disease
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
Status: Enrolling
Updated: 12/31/1969
Chattanooga Eye Institute
mi
from
Chattanooga, TN
Click here to add this to my saved trials
Safety and Efficacy of KPI-121 Compared to Placebo in Subjects With Dry Eye Disease
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
Status: Enrolling
Updated:  12/31/1969
Total Eye Care, PA
mi
from
Memphis, TN
Safety and Efficacy of KPI-121 Compared to Placebo in Subjects With Dry Eye Disease
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
Status: Enrolling
Updated: 12/31/1969
Total Eye Care, PA
mi
from
Memphis, TN
Click here to add this to my saved trials
Safety and Efficacy of KPI-121 Compared to Placebo in Subjects With Dry Eye Disease
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
Status: Enrolling
Updated:  12/31/1969
Toyos Clinic
mi
from
Nashville, TN
Safety and Efficacy of KPI-121 Compared to Placebo in Subjects With Dry Eye Disease
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
Status: Enrolling
Updated: 12/31/1969
Toyos Clinic
mi
from
Nashville, TN
Click here to add this to my saved trials
Safety and Efficacy of KPI-121 Compared to Placebo in Subjects With Dry Eye Disease
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
Status: Enrolling
Updated:  12/31/1969
Texan Eye/Keystone Research
mi
from
Austin, TX
Safety and Efficacy of KPI-121 Compared to Placebo in Subjects With Dry Eye Disease
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
Status: Enrolling
Updated: 12/31/1969
Texan Eye/Keystone Research
mi
from
Austin, TX
Click here to add this to my saved trials
Safety and Efficacy of KPI-121 Compared to Placebo in Subjects With Dry Eye Disease
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
Status: Enrolling
Updated:  12/31/1969
Cataract & Glaucoma Center
mi
from
El Paso, TX
Safety and Efficacy of KPI-121 Compared to Placebo in Subjects With Dry Eye Disease
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
Status: Enrolling
Updated: 12/31/1969
Cataract & Glaucoma Center
mi
from
El Paso, TX
Click here to add this to my saved trials
Safety and Efficacy of KPI-121 Compared to Placebo in Subjects With Dry Eye Disease
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
Status: Enrolling
Updated:  12/31/1969
Houston Eye Associates
mi
from
Houston, TX
Safety and Efficacy of KPI-121 Compared to Placebo in Subjects With Dry Eye Disease
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
Status: Enrolling
Updated: 12/31/1969
Houston Eye Associates
mi
from
Houston, TX
Click here to add this to my saved trials
Safety and Efficacy of KPI-121 Compared to Placebo in Subjects With Dry Eye Disease
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
Status: Enrolling
Updated:  12/31/1969
Advanced Laser Vision & Surgical Institute, Intouch Clinical Research Center
mi
from
Houston, TX
Safety and Efficacy of KPI-121 Compared to Placebo in Subjects With Dry Eye Disease
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
Status: Enrolling
Updated: 12/31/1969
Advanced Laser Vision & Surgical Institute, Intouch Clinical Research Center
mi
from
Houston, TX
Click here to add this to my saved trials
Safety and Efficacy of KPI-121 Compared to Placebo in Subjects With Dry Eye Disease
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
Status: Enrolling
Updated:  12/31/1969
Whitsett Vision Group
mi
from
Houston, TX
Safety and Efficacy of KPI-121 Compared to Placebo in Subjects With Dry Eye Disease
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
Status: Enrolling
Updated: 12/31/1969
Whitsett Vision Group
mi
from
Houston, TX
Click here to add this to my saved trials
Safety and Efficacy of KPI-121 Compared to Placebo in Subjects With Dry Eye Disease
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
Status: Enrolling
Updated:  12/31/1969
The Ocular Surface Institute (TOSI), University of Houston
mi
from
Houston, TX
Safety and Efficacy of KPI-121 Compared to Placebo in Subjects With Dry Eye Disease
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
Status: Enrolling
Updated: 12/31/1969
The Ocular Surface Institute (TOSI), University of Houston
mi
from
Houston, TX
Click here to add this to my saved trials
Safety and Efficacy of KPI-121 Compared to Placebo in Subjects With Dry Eye Disease
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
Status: Enrolling
Updated:  12/31/1969
Kozlovsky Delay & Winter Eye Consultants, LLC
mi
from
San Antonio, TX
Safety and Efficacy of KPI-121 Compared to Placebo in Subjects With Dry Eye Disease
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
Status: Enrolling
Updated: 12/31/1969
Kozlovsky Delay & Winter Eye Consultants, LLC
mi
from
San Antonio, TX
Click here to add this to my saved trials
Safety and Efficacy of KPI-121 Compared to Placebo in Subjects With Dry Eye Disease
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
Status: Enrolling
Updated:  12/31/1969
Hoopes Vision
mi
from
Draper, UT
Safety and Efficacy of KPI-121 Compared to Placebo in Subjects With Dry Eye Disease
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
Status: Enrolling
Updated: 12/31/1969
Hoopes Vision
mi
from
Draper, UT
Click here to add this to my saved trials
Safety and Efficacy of KPI-121 Compared to Placebo in Subjects With Dry Eye Disease
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
Status: Enrolling
Updated:  12/31/1969
Virginia Eye Consultants
mi
from
Norfolk, VA
Safety and Efficacy of KPI-121 Compared to Placebo in Subjects With Dry Eye Disease
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
Status: Enrolling
Updated: 12/31/1969
Virginia Eye Consultants
mi
from
Norfolk, VA
Click here to add this to my saved trials
Safety and Efficacy of KPI-121 Compared to Placebo in Subjects With Dry Eye Disease
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
Status: Enrolling
Updated:  12/31/1969
Spokane Eye Clinical Research
mi
from
Spokane, WA
Safety and Efficacy of KPI-121 Compared to Placebo in Subjects With Dry Eye Disease
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
Status: Enrolling
Updated: 12/31/1969
Spokane Eye Clinical Research
mi
from
Spokane, WA
Click here to add this to my saved trials
Safety and Efficacy of KPI-121 Compared to Placebo in Subjects With Dry Eye Disease
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
Status: Enrolling
Updated:  12/31/1969
Regional Eye Associates
mi
from
Morgantown, WV
Safety and Efficacy of KPI-121 Compared to Placebo in Subjects With Dry Eye Disease
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
Status: Enrolling
Updated: 12/31/1969
Regional Eye Associates
mi
from
Morgantown, WV
Click here to add this to my saved trials
Safety and Efficacy of KPI-121 Compared to Placebo in Subjects With Dry Eye Disease
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
Status: Enrolling
Updated:  12/31/1969
Brazosport Eye Institute
mi
from
Lake Jackson, TX
Safety and Efficacy of KPI-121 Compared to Placebo in Subjects With Dry Eye Disease
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
Status: Enrolling
Updated: 12/31/1969
Brazosport Eye Institute
mi
from
Lake Jackson, TX
Click here to add this to my saved trials
Safety and Efficacy of KPI-121 Compared to Placebo in Subjects With Dry Eye Disease
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
Status: Enrolling
Updated:  12/31/1969
Sall Research Medical Center, Inc.
mi
from
Artesia, CA
Safety and Efficacy of KPI-121 Compared to Placebo in Subjects With Dry Eye Disease
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
Status: Enrolling
Updated: 12/31/1969
Sall Research Medical Center, Inc.
mi
from
Artesia, CA
Click here to add this to my saved trials
Safety and Efficacy of KPI-121 Compared to Placebo in Subjects With Dry Eye Disease
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
Status: Enrolling
Updated:  12/31/1969
North Valley Eye Medical Group, Inc.
mi
from
Mission Hills, CA
Safety and Efficacy of KPI-121 Compared to Placebo in Subjects With Dry Eye Disease
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
Status: Enrolling
Updated: 12/31/1969
North Valley Eye Medical Group, Inc.
mi
from
Mission Hills, CA
Click here to add this to my saved trials
Safety and Efficacy of KPI-121 Compared to Placebo in Subjects With Dry Eye Disease
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
Status: Enrolling
Updated:  12/31/1969
Martel Eye Medical Group
mi
from
Rancho Cordova, CA
Safety and Efficacy of KPI-121 Compared to Placebo in Subjects With Dry Eye Disease
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
Status: Enrolling
Updated: 12/31/1969
Martel Eye Medical Group
mi
from
Rancho Cordova, CA
Click here to add this to my saved trials
Safety and Efficacy of KPI-121 Compared to Placebo in Subjects With Dry Eye Disease
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
Status: Enrolling
Updated:  12/31/1969
Scott & Christie and Associates, PC
mi
from
Cranberry Township, PA
Safety and Efficacy of KPI-121 Compared to Placebo in Subjects With Dry Eye Disease
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
Status: Enrolling
Updated: 12/31/1969
Scott & Christie and Associates, PC
mi
from
Cranberry Township, PA
Click here to add this to my saved trials
Safety and Efficacy of KPI-121 Compared to Placebo in Subjects With Dry Eye Disease
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
Status: Enrolling
Updated:  12/31/1969
Tekwani Vision Center
mi
from
Saint Louis, MO
Safety and Efficacy of KPI-121 Compared to Placebo in Subjects With Dry Eye Disease
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
Status: Enrolling
Updated: 12/31/1969
Tekwani Vision Center
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Evaluation of P-321 Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Disease
Randomized, Double-Masked, Parallel Group Study of P-321 Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Disease Assessing Safety and Efficacy Over 28 Days
Status: Enrolling
Updated:  12/31/1969
Tauber Eye Center
mi
from
Kansas City, MO
Evaluation of P-321 Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Disease
Randomized, Double-Masked, Parallel Group Study of P-321 Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Disease Assessing Safety and Efficacy Over 28 Days
Status: Enrolling
Updated: 12/31/1969
Tauber Eye Center
mi
from
Kansas City, MO
Click here to add this to my saved trials
Evaluation of P-321 Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Disease
Randomized, Double-Masked, Parallel Group Study of P-321 Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Disease Assessing Safety and Efficacy Over 28 Days
Status: Enrolling
Updated:  12/31/1969
Comprehensive Eye Care Ltd
mi
from
Washington, MO
Evaluation of P-321 Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Disease
Randomized, Double-Masked, Parallel Group Study of P-321 Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Disease Assessing Safety and Efficacy Over 28 Days
Status: Enrolling
Updated: 12/31/1969
Comprehensive Eye Care Ltd
mi
from
Washington, MO
Click here to add this to my saved trials
Evaluation of P-321 Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Disease
Randomized, Double-Masked, Parallel Group Study of P-321 Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Disease Assessing Safety and Efficacy Over 28 Days
Status: Enrolling
Updated:  12/31/1969
Ocular Surface Center, Baylor College of Medicine
mi
from
Houston, TX
Evaluation of P-321 Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Disease
Randomized, Double-Masked, Parallel Group Study of P-321 Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Disease Assessing Safety and Efficacy Over 28 Days
Status: Enrolling
Updated: 12/31/1969
Ocular Surface Center, Baylor College of Medicine
mi
from
Houston, TX
Click here to add this to my saved trials
Evaluation of P-321 Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Disease
Randomized, Double-Masked, Parallel Group Study of P-321 Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Disease Assessing Safety and Efficacy Over 28 Days
Status: Enrolling
Updated:  12/31/1969
Sall Research Medical Center, Inc.
mi
from
Artesia, CA
Evaluation of P-321 Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Disease
Randomized, Double-Masked, Parallel Group Study of P-321 Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Disease Assessing Safety and Efficacy Over 28 Days
Status: Enrolling
Updated: 12/31/1969
Sall Research Medical Center, Inc.
mi
from
Artesia, CA
Click here to add this to my saved trials
Evaluation of P-321 Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Disease
Randomized, Double-Masked, Parallel Group Study of P-321 Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Disease Assessing Safety and Efficacy Over 28 Days
Status: Enrolling
Updated:  12/31/1969
Ophthalmology Associates
mi
from
Saint Louis, MO
Evaluation of P-321 Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Disease
Randomized, Double-Masked, Parallel Group Study of P-321 Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Disease Assessing Safety and Efficacy Over 28 Days
Status: Enrolling
Updated: 12/31/1969
Ophthalmology Associates
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Evaluation of P-321 Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Disease
Randomized, Double-Masked, Parallel Group Study of P-321 Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Disease Assessing Safety and Efficacy Over 28 Days
Status: Enrolling
Updated:  12/31/1969
UNC Kittner Eye Center
mi
from
Chapel Hill, NC
Evaluation of P-321 Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Disease
Randomized, Double-Masked, Parallel Group Study of P-321 Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Disease Assessing Safety and Efficacy Over 28 Days
Status: Enrolling
Updated: 12/31/1969
UNC Kittner Eye Center
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Evaluation of P-321 Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Disease
Randomized, Double-Masked, Parallel Group Study of P-321 Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Disease Assessing Safety and Efficacy Over 28 Days
Status: Enrolling
Updated:  12/31/1969
Virginia Eye Consultants
mi
from
Norfolk, VA
Evaluation of P-321 Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Disease
Randomized, Double-Masked, Parallel Group Study of P-321 Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Disease Assessing Safety and Efficacy Over 28 Days
Status: Enrolling
Updated: 12/31/1969
Virginia Eye Consultants
mi
from
Norfolk, VA
Click here to add this to my saved trials